Global Immune Repertoire Sequencing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 151599
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Pharmaceuticals and Healthcare

Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.

Scope of the Report:

The global Immune Repertoire Sequencing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immune Repertoire Sequencing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Immune Repertoire Sequencing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immune Repertoire Sequencing market by product type and applications/end industries.

Market Segment by Companies, this report covers

ArcherDX

Junom Therapeutics

Roche Holding

Illumina

ThermoFisher Scietific

Pacific Biosciences

CD Genomics

Atreca

Adaptive Biotechnologies

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pyro-Sequencing

Dye-Terminating Sequencing

Semiconductor Sequencing

Others

Market Segment by Applications, can be divided into

Biomarker Discovery

Infectious Diseases

Vaccine Development and Efficacy

Cancer Immunotherapy

Autoimmune Disease

Transplant Rejection and Tolerance

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Immune Repertoire Sequencing Market Overview

1.1 Product Overview and Scope of Immune Repertoire Sequencing

1.2 Classification of Immune Repertoire Sequencing by Types

1.2.1 Global Immune Repertoire Sequencing Revenue Comparison by Types (2017-2023)

1.2.2 Global Immune Repertoire Sequencing Revenue Market Share by Types in 2017

1.2.3 Pyro-Sequencing

1.2.4 Dye-Terminating Sequencing

1.2.5 Semiconductor Sequencing

1.2.6 Others

1.3 Global Immune Repertoire Sequencing Market by Application

1.3.1 Global Immune Repertoire Sequencing Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Biomarker Discovery

1.3.3 Infectious Diseases

1.3.4 Vaccine Development and Efficacy

1.3.5 Cancer Immunotherapy

1.3.6 Autoimmune Disease

1.3.7 Transplant Rejection and Tolerance

1.3.8 Others

1.4 Global Immune Repertoire Sequencing Market by Regions

1.4.1 Global Immune Repertoire Sequencing Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Immune Repertoire Sequencing Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Immune Repertoire Sequencing Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immune Repertoire Sequencing Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Immune Repertoire Sequencing Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immune Repertoire Sequencing Status and Prospect (2013-2023)

1.5 Global Market Size of Immune Repertoire Sequencing (2013-2023)

2 Manufacturers Profiles

2.1 ArcherDX

2.1.1 Business Overview

2.1.2 Immune Repertoire Sequencing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ArcherDX Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.2 Junom Therapeutics

2.2.1 Business Overview

2.2.2 Immune Repertoire Sequencing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Junom Therapeutics Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.3 Roche Holding

2.3.1 Business Overview

2.3.2 Immune Repertoire Sequencing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Roche Holding Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.4 Illumina

2.4.1 Business Overview

2.4.2 Immune Repertoire Sequencing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Illumina Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.5 ThermoFisher Scietific

2.5.1 Business Overview

2.5.2 Immune Repertoire Sequencing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 ThermoFisher Scietific Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pacific Biosciences

2.6.1 Business Overview

2.6.2 Immune Repertoire Sequencing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pacific Biosciences Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.7 CD Genomics

2.7.1 Business Overview

2.7.2 Immune Repertoire Sequencing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 CD Genomics Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.8 Atreca

2.8.1 Business Overview

2.8.2 Immune Repertoire Sequencing Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Atreca Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

2.9 Adaptive Biotechnologies

2.9.1 Business Overview

2.9.2 Immune Repertoire Sequencing Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Adaptive Biotechnologies Immune Repertoire Sequencing Revenue, Gross Margin and Market Share (2016-2017)

3 Global Immune Repertoire Sequencing Market Competition, by Players

3.1 Global Immune Repertoire Sequencing Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Immune Repertoire Sequencing Players Market Share

3.2.2 Top 10 Immune Repertoire Sequencing Players Market Share

3.3 Market Competition Trend

4 Global Immune Repertoire Sequencing Market Size by Regions

4.1 Global Immune Repertoire Sequencing Revenue and Market Share by Regions

4.2 North America Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

4.3 Europe Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

4.5 South America Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

5 North America Immune Repertoire Sequencing Revenue by Countries

5.1 North America Immune Repertoire Sequencing Revenue by Countries (2013-2018)

5.2 USA Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

5.3 Canada Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

5.4 Mexico Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

6 Europe Immune Repertoire Sequencing Revenue by Countries

6.1 Europe Immune Repertoire Sequencing Revenue by Countries (2013-2018)

6.2 Germany Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

6.3 UK Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

6.4 France Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

6.5 Russia Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

6.6 Italy Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Immune Repertoire Sequencing Revenue by Countries

7.1 Asia-Pacific Immune Repertoire Sequencing Revenue by Countries (2013-2018)

7.2 China Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

7.3 Japan Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

7.4 Korea Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

7.5 India Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

8 South America Immune Repertoire Sequencing Revenue by Countries

8.1 South America Immune Repertoire Sequencing Revenue by Countries (2013-2018)

8.2 Brazil Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

8.3 Argentina Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

8.4 Colombia Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Immune Repertoire Sequencing by Countries

9.1 Middle East and Africa Immune Repertoire Sequencing Revenue by Countries (2013-2018)

9.2 Saudi Arabia Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

9.3 UAE Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

9.4 Egypt Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

9.5 Nigeria Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

9.6 South Africa Immune Repertoire Sequencing Revenue and Growth Rate (2013-2018)

10 Global Immune Repertoire Sequencing Market Segment by Type

10.1 Global Immune Repertoire Sequencing Revenue and Market Share by Type (2013-2018)

10.2 Global Immune Repertoire Sequencing Market Forecast by Type (2018-2023)

10.3 Pyro-Sequencing Revenue Growth Rate (2013-2023)

10.4 Dye-Terminating Sequencing Revenue Growth Rate (2013-2023)

10.5 Semiconductor Sequencing Revenue Growth Rate (2013-2023)

10.6 Others Revenue Growth Rate (2013-2023)

11 Global Immune Repertoire Sequencing Market Segment by Application

11.1 Global Immune Repertoire Sequencing Revenue Market Share by Application (2013-2018)

11.2 Immune Repertoire Sequencing Market Forecast by Application (2018-2023)

11.3 Biomarker Discovery Revenue Growth (2013-2018)

11.4 Infectious Diseases Revenue Growth (2013-2018)

11.5 Vaccine Development and Efficacy Revenue Growth (2013-2018)

11.6 Cancer Immunotherapy Revenue Growth (2013-2018)

11.7 Autoimmune Disease Revenue Growth (2013-2018)

11.8 Transplant Rejection and Tolerance Revenue Growth (2013-2018)

11.9 Others Revenue Growth (2013-2018)

12 Global Immune Repertoire Sequencing Market Size Forecast (2018-2023)

12.1 Global Immune Repertoire Sequencing Market Size Forecast (2018-2023)

12.2 Global Immune Repertoire Sequencing Market Forecast by Regions (2018-2023)

12.3 North America Immune Repertoire Sequencing Revenue Market Forecast (2018-2023)

12.4 Europe Immune Repertoire Sequencing Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Immune Repertoire Sequencing Revenue Market Forecast (2018-2023)

12.6 South America Immune Repertoire Sequencing Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Immune Repertoire Sequencing Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Immune Repertoire Sequencing Picture

Table Product Specifications of Immune Repertoire Sequencing

Table Global Immune Repertoire Sequencing and Revenue (Million USD)

Please fill the form below, to recieve the report sample


+1